Straits Times Index
2,497.71-3.07(-0.12%)S&P 500
3,319.47-37.54(-1.12%)Dow
27,657.42-244.58(-0.88%)
Geron Corporation (GERN)
| Previous close | 1.8400 |
| Open | 1.8900 |
| Bid | 2.0000 x 3100 |
| Ask | 2.0100 x 21500 |
| Day's range | 1.8400 - 2.0000 |
| 52-week range | 0.7500 - 2.4000 |
| Volume | 23,380,917 |
| Avg. volume | 3,053,114 |
| Market cap | 645.293M |
| Beta (5Y monthly) | 1.66 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3660 |
| Earnings date | 06 Aug 2020 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 4.00 |
- Business Wire
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (Nasdaq: GERN) today reported that it has granted a non-statutory stock option to purchase an aggregate of 80,000 shares of Geron common stock as an inducement to a newly-hired employee in connection with commencement of employment with the Company.
- Business Wire
Geron to Present at the H.C. Wainwright Global Investment Conference
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, will present a company overview at the H.C. Wainwright 22nd Annual Global Investment Conference, to be hosted in a virtual format, on Monday, September 14, 2020 at 2:30 p.m. ET.
- Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation (Nasdaq: GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 270,000 shares of Geron common stock as inducements to four newly-hired employees in connection with commencement of employment with the Company.
